Skip to main content

COSTE-UTILIDAD Y EFECTOS FISIOLOGICOS DE LA TERAPIA DE ACEPTACION Y COMPROMISO Y LA ACTIVACION CONDUCTUAL EN PACIENTES CON DOLOR CRONICO Y DEPRESION MAYOR COMORBIDA (PROYECTO IMPACT)

PI19/00112

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU
Execution centre PARC SANITARI SANT JOAN DE DEU

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A systematic review of cognitive behavioral therapy-based interventions for comorbid chronic pain and clinically relevant psychological distress

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Colomer-Carbonell, Ariadna|||0000-0001-8923-6316
  • Fernández-Vázquez, Óscar
  • Noboa-Rocamora, Georgina
  • Cardona-Ros, Gemma
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Montes-Pérez, Antonio
  • Castaño Asins, Juan Ramon|||0000-0001-6571-503X
  • Edo Izquierdo, Sílvia|||0000-0002-6564-3475
  • Borràs, Xavier|||0000-0003-3972-1385
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
Chronic pain frequently co-occurs with clinically relevant psychological distress. A systematic review was conducted to identify the efficacy of cognitive behavioral therapy-based interventions for patients with these comorbid conditions. The systematic search was carried out in Medline, PsycINFO, Web of Science, and Scopus up to March 18th, 2023. Four reviewers independently conducted screenings, extraction, and quality assessment. Twelve randomized controlled trials and one non-randomized controlled trial involving 1,661 participants that examined the efficacy of Cognitive Behavioral Therapy (nine studies), Mindfulness-based Interventions (three studies), Acceptance and Commitment Therapy (one study), and Behavioral Activation Therapy for Depression (one study) were included. Compared to treatment as usual, six out of eight studies of traditional Cognitive Behavioral Therapy reported significant differences in the reduction of depressive symptoms at post-treatment (d from 1.31 to 0.18) and four out of six at follow-up (d from 0.75 to 0.26); similarly, five out of six reported significant differences in the reduction of anxiety symptoms at post-treatment (d from 1.08 to 0.19) and three out of four at follow-up (d from 1.07 to 0.27). Overall, no significant differences between traditional Cognitive Behavioral Therapy and treatment as usual were reported at post-treatment and follow-up in the studies exploring pain intensity and pain catastrophizing. The available evidence suggests that traditional Cognitive Behavioral Therapy may produce significant benefits for the improvement of depression, anxiety, and quality of life, but not for pain intensity and pain catastrophizing. More evidence is needed to determine the effects of MBI, ACT, and BATD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Predicting adherence and clinical response of cognitive behavioral therapy among individuals with chronic low back pain plus depressive symptoms, a secondary analysis of a randomized controlled trial

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Robles, Brenda|||0000-0001-6023-7809
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Luciano, Juan Vicente|||0000-0003-0750-1599
BACKGROUND: Identifying predictors for adherence and clinical response to psychological therapies is essential for improving individual treatment outcomes. OBJECTIVE: To explore predictors of adherence and clinical response among individuals with co-occurring chronic low back pain (CLBP) and depression receiving cognitive behavioral therapy (CBT). METHODS: This study employs a secondary analysis of data from a randomized controlled trial (NCT04140838), including 156 individuals with CLBP plus depressive symptoms who received CBT. Multiple linear regression analyses were conducted to assess the predictive power of sociodemographic, health status, pain-related, and therapy-related variables on adherence and clinical response. Adherence was measured by therapy progress (number of completed sessions) and therapy completion (attendance at least six out of eight sessions). Clinical response was assessed by a clinically relevant reduction in posttreatment pain interference. RESULTS: Older age, higher therapy credibility, and higher education level predicted greater therapy progress, while higher therapy credibility and lower baseline stress levels predicted greater therapy completion. In addition, higher opioid use, baseline pain interference, and baseline depression levels predicted lower clinical response; in contrast, higher behavioral activation levels, older age, and unemployment predicted higher clinical response. CONCLUSION: Therapy credibility, age, and education level are key predictors of adherence, and baseline levels of pain interference, depression, and behavioral activation are key predictors of clinical response. These findings may inform opportunities to develop more effective personalized therapeutic plans for individuals with CLBP and depression.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acceptance and commitment therapy in chronic low back pain and comorbid depression, a single-case study with idiographic network analysis

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Gallego, Ana|||0000-0002-8060-2495
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Suso-Ribera, Carlos|||0000-0002-2655-1017
  • García Palacios, Azucena|||0000-0001-9250-8714
  • Hayes, Steven C.|||0000-0003-4399-6859
  • Hofmann, Stefan G.|||0000-0002-3548-9681
  • Ciarrochi, Joseph|||0000-0003-0471-8100
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Luciano, Juan Vicente|||0000-0003-0750-1599
This study analyzed the efficacy of acceptance and commitment therapy (ACT) in six individuals with chronic low back pain plus depressive symptoms using an idiographic approach within a randomized controlled trial. Daily ecological momentary assessments (EMA) and full assessments at baseline, posttreatment, and follow-up were collected. Outcomes included pain interference, pain intensity, and depressed mood, and the process variable was psychological inflexibility. Analyses involved visual inspection, non-overlap of all pairs, Tau, Tau-U, and idiographic network analysis. Moderate improvements were observed in pain interference (5/6), depressed mood (5/6), and psychological inflexibility (3/6), with limited change in pain intensity (1/6). Most participants (4/6) reported an overall relevant improvement. Idiographic networks showed considerable variability across participants, with psychological inflexibility and depressed mood playing a central role. Findings suggest ACT may help reduce pain interference and depressed mood, highlighting the need for personalized approaches and the continued use of single-case methods combined with EMA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression, study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study)

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Forero, Carlos G.|||0000-0002-5245-0076
  • Cristóbal Narváez, Paula|||0000-0001-8184-6347
  • Suso-Ribera, Carlos|||0000-0002-2655-1017
  • García Palacios, Azucena|||0000-0001-9250-8714
  • Colomer-Carbonell, Ariadna|||0000-0001-8923-6316
  • Pérez-Aranda, Adrián|||0000-0002-1602-3413
  • Andrés Rodríguez, Laura|||0000-0001-5133-9811
  • McCracken, Lance M.|||0000-0002-9734-0153
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Estivill, Pere|||0000-0002-7917-6134
  • Carreras-Marcos, Bernat|||0000-0001-5224-1453
  • Montes-Pérez, Antonio
  • Comps, Olga|||0000-0002-0977-477X
  • Esteve, Montserrat|||0000-0003-2128-7859
  • Grasa, Mar
  • Rosa de la Cruz, Araceli|||0000-0001-6935-3785
  • Cuesta-Vargas, Antonio I.|||0000-0002-8880-4315
  • Maes, Michael|||0000-0002-2012-871X
  • Borràs, Xavier|||0000-0003-3972-1385
  • Edo Izquierdo, Sílvia|||0000-0002-6564-3475
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Castaño Asins, Juan Ramon|||0000-0001-6571-503X
  • Luciano, Juan Vicente|||0000-0003-0750-1599
The IMPACT study focuses on chronic low back pain (CLBP) and depression symptoms, a prevalent and complex problem that represents a challenge for health professionals. Acceptance and Commitment Therapy (ACT) and Brief Behavioural Activation Treatment for Depression (BATD) are effective treatments for patients with persistent pain and depression, respectively. The objectives of this 12 month, multicentre, randomised, controlled trial (RCT) are (i) to examine the efficacy and cost-utility of adding a group-based form of ACT or BATD to treatment-as-usual (TAU) for patients with CLBP and moderate to severe levels of depressive symptoms; (ii) identify pre-post differences in levels of some physiological variables and (iii) analyse the role of polymorphisms in the FKBP5 gene, psychological process measures and physiological variables as mediators or moderators of long-term clinical changes. Participants will be 225 patients with CLBP and moderate to severe depression symptoms recruited at Parc Sanitari Sant Joan de Déu (St. Boi de Llobregat, Spain) and Hospital del Mar (Barcelona, Spain), randomly allocated to one of the three study arms: TAU vs TAU+ACT versus TAU+BATD. A comprehensive assessment to collect clinical variables and costs will be conducted pretreatment, post-treatment and at 12 months follow-up, being pain interference the primary outcome measure. The following physiological variables will be considered at pretreatment and post-treatment assessments in 50% of the sample: immune-inflammatory markers, hair cortisol and cortisone, serum cortisol, corticosteroid-binding globulin and vitamin D. Polymorphisms in the FKBP5 gene (rs3800373, rs9296158, rs1360780, rs9470080 and rs4713916) will be analysed at baseline assessment. Moreover, we will include mobile-technology-based ecological momentary assessment, through the Pain Monitor app, to track ongoing clinical status during ACT and BATD treatments. Linear mixed-effects models using restricted maximum likelihood, and a full economic evaluation applying bootstrapping techniques, acceptability curves and sensitivity analyses will be computed. This study has been approved by the Ethics Committee of the Fundació Sant Joan de Déu and Hospital del Mar. The results will be actively disseminated through peer-reviewed journals, conference presentations, social media and various community engagement activities.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Immune-inflammatory and hypothalamic-pituitary-adrenal axis biomarkers are altered in patients with non-specific low back pain, A systematic review

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • Colomer-Carbonell, Ariadna|||0000-0001-8923-6316
  • Carmona Cervelló, Meritxell|||0000-0003-0907-9168
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Borràs, Xavier|||0000-0003-3972-1385
  • Grasa, Mar
  • Esteve, Montserrat|||0000-0003-2128-7859
  • Maes, Michael|||0000-0002-2012-871X
  • Edo Izquierdo, Sílvia|||0000-0002-6564-3475
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
  • Luciano, Juan Vicente|||0000-0003-0750-1599
, identifier CRD42020176153.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Economic evaluation of videoconference group acceptance and commitment therapy and behavioral activation therapy for depression versus usual care among adults with chronic low back pain plus comorbid depressive symptoms

  • Sanabria-Mazo, Juan P.|||0000-0003-1688-435X
  • D'Amico, Francesco|||0000-0001-7995-826X
  • Cardeñosa, Eugenia|||0000-0002-9735-2269
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
  • Edo Izquierdo, Sílvia|||0000-0002-6564-3475
  • Borràs, Xavier|||0000-0003-3972-1385
  • McCracken, Lance M.|||0000-0002-9734-0153
  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Sanz Ruiz, Antoni|||0000-0002-7952-4477
  • Luciano, Juan Vicente|||0000-0003-0750-1599
Chronic pain and depression are frequently comorbid conditions associated with significant healthcare and social costs.This study examined the cost-utility and cost-effectiveness of videoconference-based group forms of Acceptance and Commitment Therapy (ACT) and Behavioral Activation Therapy for Depression (BATD), as a complement to treatment-as-usual (TAU), for patients with chronic low back pain (CLBP) plus depressive symptoms, compared to TAU alone. A trial-based economic evaluation (n = 234) was conducted from a governmental and healthcare perspective with a time horizon of 12 months. Primary outcomes were the Brief Pain Inventory-Interference Scale (BPI-IS) and Quality Adjusted Life Year (QALY). Compared to TAU, ACT achieved a significant reduction in total costs (d = 0.47), and BATD achieved significant reductions in indirect (d = 0.61) and total costs (d = 0.63). Significant improvements in BPI-IS (d = 0.73 and d = 0.66, respectively) and QALY scores (d = 0.46 and d = 0.28, respectively) were found in ACT and BATD compared to TAU. No significant differences in costs and outcomes were found between ACT and BATD. In the intention-to-treat analyses, from the governmental and healthcare perspective, no significant differences in cost reduction and incremental effects were identified in the comparison between ACT, BATD, and TAU. However, in the complete case analysis, significant incremental effects of ACT (∆BPI-IS = -1.57 and -1.39, respectively) and BATD (∆BPI-IS = -1.08 and -1.04, respectively) compared with TAU were observed. In the per-protocol analysis, only the significant incremental effects of ACT (∆BPI-IS = -1.68 and -1.43, respectively) compared to TAU were detected. In conclusion, ACT and BATD might be efficient options in the management of CLBP plus comorbid depression symptoms as compared to usual care. However, no clear difference was found in the comparison between the two active therapies regarding cost-effectiveness or cost-utility. PERSPECTIVE: The economic evaluation of psychological therapies for the management of complex conditions is crucial as can be used in decision-making and resource allocation. This study provides evidence that videoconference group-based forms of ACT and BATD are more effective and involve a greater reduction in costs than usual care in the management of CLBP plus comorbid depressive symptoms. Both psychological therapies seem to offer good value for money to the Spanish national health service and the government.